View Article

Abstract

Asthma is a chronic inflammatory respiratory disorder characterized by airway hyperresponsiveness, mucosal inflammation, and reversible airflow obstruction. Inhaled corticosteroids such as Beclomethasone, Budesonide, and Fluticasone remain the cornerstone of asthma management; however, their prolonged use is associated with local and systemic adverse effects including throat irritation, immunosuppression, adrenal suppression, and mucosal dryness, which may reduce patient compliance and quality of life.The present study aims to formulate and evaluate a herbal aromagel as a complementary therapeutic approach to mitigate corticosteroid-induced adverse effects while supporting respiratory health. The formulation incorporates bioactive herbal constituents such as Ginseng, Asperuloside, and Eriodictyol, known for their anti-inflammatory, antioxidant, bronchodilatory, and immunomodulatory properties.The aromagel is designed as a semi-solid topical system that enables both transdermal absorption and inhalation of volatile compounds, providing dual therapeutic action. Physicochemical parameters including pH, viscosity, spreadability, and stability were evaluated. Phytochemical screening was performed to confirm the presence of active constituents, and safety assessment included skin irritation studies.The results suggest that the herbal aromagel possesses desirable physicochemical characteristics and demonstrates potential in reducing inflammation, oxidative stress, and airway reactivity. The synergistic action of herbal components may help counteract the adverse effects associated with long-term corticosteroid therapy.This study highlights the potential of herbal aromagel as a novel, safe, and effective adjunctive therapy for improving respiratory health and enhancing patient compliance in asthma management.

Keywords

Asthma, Herbal aromagel, Inhaled corticosteroids, Adverse effects, Bronchodialator, Antioxidant, Aromatherapy, Asperuloside, Eriodictyol

Introduction

Asthma is a chronic inflammatory respiratory disorder commonly treated with inhaled corticosteroids such as Beclomethasone, Budesonide, and Fluticasone. Although effective, prolonged use of these drugs may lead to adrenal suppression and immune suppression, resulting in fatigue, stress intolerance, and increased susceptibility to infections.

Asthma is a long-term condition marked by persistent inflammation in the airways. Various types of immune and structural cells, such as mast cells, eosinophills, T cells,  macrophages, neutrophills, and epithelial cells, are involved in the disease process. In individuals who are susceptible, this inflammation leads to repeated episodes of symptoms like wheezing, shortness of breath, chest tightness, and coughing, especially during the night or early morning hours. These flare-ups are commonly linked to widespread but changeable narrowing of the airways, which can typically improve either on its own or with medical intervention. The underlying inflammation also increases the sensitivity of the airways to different triggers. While many individuals experience full reversal of airflow limitation, in some cases, this reversal may be only partial.

Adverse effects of inhaled corticosteroids and their causes:

Inhaled corticosteroids used in asthma, such as beclomethasone dipropionate can produce both local and systemic adverse effects due to their pharmacological action and site of deposition. Local airway irritation may occur when drug particles deposit on the trachea, bronchi, and larynx, causing cough, throat irritation, hoarseness, and sometimes paradoxical bronchospasm due to reflex activation of airway sensory nerves. Local immunosuppression in the oral and pharyngeal mucosa reduces host defense mechanisms, leading to infections such as oral candidiasis and increased susceptibility to respiratory infections. Deposition of corticosteroids on the laryngeal muscles can result in steroid-induced myopathy, causing voice changes and dysphonia. With long-term or high-dose use, a portion of the drug may be systemically absorbed, suppressing the hypothalamic pituitary adrenal axis through negative feedback inhibition of cortisol secretion, which can lead to adrenal suppression and reduced stress response.Although effective, long-term corticosteroid therapy is associated with adverse effects including throat irritation, immune suppression, adrenal suppression, mucosal dryness, cough, and paradoxical bronchospasm. These side effects reduce patient compliance and quality of life.

Herbal Aromagel

An aromagel is a semi-solid topical gel formulation containing volatile aromatic compounds and herbal extracts, designed to release therapeutic vapors for inhalation while also allowing local transdermal absorption. It combines the advantages of aromatherapy and gel-based drug delivery.

Herbal aromatherapy offers a complementary approach by delivering volatile bioactive compounds through inhalation and topical absorption, producing rapid local and systemic effects. Medicinal plants such as Thyme, Menthol, Ginger, Licorice, Ginseng, Basil (Tulsi) and bioactive compounds like Asperuloside and Eriodictyol possess anti-inflammatory, bronchodilatory, antioxidant, immunomodulatory, and mucoprotective properties. Incorporating these agents into a herbal aromatherapy gel may help counteract corticosteroid-induced adverse effects while supporting respiratory health.

These bioactive compounds interact with multiple cellular and molecular targets, modulating signaling pathways involved in inflammation, oxidative stress, and immune responses. The inhaled volatile agents directly affect the airway mucosa and smooth muscle, promoting bronchodilation and reducing inflammation, while the transdermally absorbed compounds contribute to systemic immunomodulation and tissue repair. Additionally, the antioxidant properties of these compounds help neutralize reactive oxygen species generated during respiratory diseases or corticosteroid therapy, thereby protecting lung tissues from oxidative damage. The synergistic action of diverse herbal constituents in the gel matrix not only supports respiratory function but also offers a complementary approach to counteract the adverse effects of long-term corticosteroid use, such as mucosal thinning and immune suppression. Theoretically, aromagels represent an innovative platform that integrates phytochemical complexity with advanced drug delivery principles, optimizing therapeutic efficacy while minimizing systemic side effects. Through controlled vapor release and skin absorption, aromagels provide a holistic and multifaceted means to support respiratory health, reduce inflammation, and enhance overall well-being.

MATERIAL AND METHODOLOGY

Materials

Eriodictyol and asperuloside were used as primary active phytoconstituents. The herbal materials selected included ginger (Zingiber officinale), ginseng (Panax ginseng), licorice (Glycyrrhiza glabra), basil (Ocimum basilicum), and thyme (Thymus vulgaris), based on their reported anti-inflammatory, bronchodilatory, and antioxidant properties.

Carbopol 940 was used as a gelling agent, Polysorbate 20 as a solubilizing agent, and propyl paraben as a preservative. Purified water was used as the vehicle. All chemicals and reagents used were of analytical grade and obtained from authenticated suppliers.

Methodology

1. Preparation of Herbal Extracts

The crude plant materials were washed, shade-dried, and coarsely powdered. The powdered drugs were subjected to maceration using hydroalcoholic solvent (ethanol:water, 70:30) for 48-72 hours with occasional stirring. The extracts were filtered using muslin cloth followed by Whatman filter paper and concentrated using a water bath at controlled temperature (40-50°C). The concentrated extracts were stored in airtight containers for further use.

2. Preparation of Carbopol Gel Base

Carbopol 940 was pre-wetted with a small amount of glycerin to prevent clumping and then dispersed in purified water under continuous stirring. The dispersion was allowed to hydrate completely to form a uniform gel base. Air bubbles entrapped during mixing were removed by gentle sonication. The gel base was stored in a closed container to prevent contamination.

3. Incorporation of Herbal Extracts and Essential Oils

The prepared herbal extracts and essential oils were added gradually to the gel base with continuous gentle stirring to ensure uniform distribution. Compatibility of ingredients was confirmed by observing any phase separation or precipitation. Care was taken to avoid excessive stirring to prevent foam formation.

4. Final Adjustment and Homogenization

The formulation was homogenized using a mechanical homogenizer to obtain a smooth and uniform consistency. The pH of the gel was adjusted and maintained within the suitable range (6.5-7.0). The formulation was evaluated for uniformity and absence of aggregates.

5. Filling and Packaging

The final gel was filled into suitable containers under hygienic conditions. Proper packaging materials were selected to protect the formulation from light, moisture, and contamination. The containers were labeled with batch number, manufacturing date, expiry date, and storage instructions, and stored under controlled condition

6. Preformulation Studies

Preformulation studies of herbal extracts were carried out to determine:

  • Organoleptic properties (color, odor, appearance)
  • Solubility in various solvents
  • pH of extract solution
  • Compatibility with excipients
  • These studies ensured stability and compatibility of ingredients before formulation.

Ingredients of Herbal Aromagel

 

Table 1 : Ingredients used in Herbal aromagel

 

Sr.No

Name of Material

Type

Purpose

1

Eriodictyol

Active Ingredient

Provides antioxidant activity which protects airway tissues

2

Asperuloside

Active Ingredient

Helps in healing irritated mucosa

3

Ginger

Active Ingredient

Provides anti-inflammatory effect

4

Ginseng

Active Ingredient

Provides immunomodulatory effect

5

Licorice

Active Ingredient

Provides soothing effect

6

Basil

Active Ingredient

Supports lung function

7

Thyme

Active Ingredient

Provides expectorant action

8

Carbopol 940

Gelling Agent

Gelling agent that gives structure to the formulation

9

Polysorbate 20

Solubilizer

Solubilizer

10

Propyl Paraben

Preservative

Preservative to prevent microbial growth

11

Purified Water

Vehicle

Solvent and base for gel preparation

 

Formulation of Herbal Aromagel

 

 

Table No 2 : Formulation Table

 

Sr.No

Ingredients

F1

F2

F3

Function

1

Eriodictyol Extract

0.02 ml

0.03 ml

0.03 ml

Antioxidant

2

Asperuloside Extract

0.03 ml

0.03 ml

0.03 ml

Anti-inflammatory action

3

Ginger Extract

0.08 ml

0.07 ml

0.08 ml

Bronchial relief

4

Ginseng Extract

0.08 ml

0.08 ml

0.08 ml

Immune support

5

Licorice Extract

0.08 ml

0.09 ml

0.08 ml

Mucosal soothing

6

Basil Extract

0.05 ml

0.06 ml

0.05 ml

Antimicrobial  action

7

Thyme Extract

0.04 ml

0.05 ml

0.05 ml

Antifungal action

8

Carbopol 940

0.5 gm

0.5 gm

0.5 gm

Gelling agent

9

Polysorbate 20

0.1 gm

0.1 gm

0.1 gm

Solubilizing agent

10

Propyl Paraben

0.01 gm

0.01 gm

0.01 gm

Preservative

 

Evaluation Parameters

Evaluation Parameters

  1. Organoleptic character

Table No. 3 : Evaluation parameter

Sr.No

Test

Result

1

Colour

Pale yellow to brown

2

Odour

Aromatic

3

Texture

Smooth

4

Constistency

Semi-solid

  1. pH Measurment

The pH of the formulated aromagel was measured using a calibrated pH meter and found to be

6.5.

The ideal pH of skin is 5.5 to 7.0.

 

 

         

       

 

Figure No 1 : pH Test

 

  1. Spreadability

The herbal aromagel demonstrated excellent spreadability, allowing it to be evenly and smoothly applied over the skin surface with minimal effort. When a small amount of gel was placed between two glass slides, it spread uniformly without breaking or forming lumps, indicating good flow properties. This facilitated easy coverage of the affected area, enhancing user comfort and ensuring efficient delivery of the herbal actives. The balanced viscosity and non-sticky nature of the gel contributed to its superior spreadability, making it suitable for regular topical use.

Procedure:

  1. A fixed amount of gel is placed between two glass slides.
  2. weight is placed on the top slide for 5 minutes to  compress the gel ito a thin layer.
  3. The weight is then removed  and see the difference.

 

 

 

Figure No 2 : Spreadability Test

  1. Washability

Washability refers to how the gel can be removed from the skin using water. This is important for user convenience and hygiene especially for products used multiple times a da or over large skin areas.

Procedure:

  1. A small quantity of gel is applied to a marked area on the skin.
  2. It is allowed to sit for a few minutes.
  3. The area then rinsed with water.

 

 

    

 

Before wash                                                             After wash

Figure No 3 : Washability Test

 

RESULT AND DISCUSSION

The formulated herbal aromagel was successfully prepared and evaluated for various physicochemical and organoleptic parameters. The results obtained indicate that the formulation possesses desirable characteristics suitable for topical application and aromatherapeutic use.

  • The colour of the formulation was observed to be pale yellow to brown, which is attributed to the presence of natural herbal extracts and phytoconstituents. This indicates successful incorporation of plant-based ingredients without any undesirable discoloration.
  • The odour of the gel was aromatic, confirming the presence of essential oils and volatile components. This aromatic property is beneficial for inhalation therapy, contributing to the overall therapeutic effect of the formulation.
  • The texture of the gel was found to be smooth, indicating proper hydration of the gelling agent, Carbopol 940 and uniform dispersion of active ingredients. A smooth texture enhances patient acceptability and ease of application.
  • The pH of the formulation was found to be 6.5, which is within the acceptable range for topical preparations. This ensures skin compatibility and minimizes the risk of irritation upon application.
  • The spreadability of the gel was found to be good, suggesting that the formulation can be easily applied over the skin surface without excessive friction. This property is essential for uniform drug distribution.
  • The viscosity of the gel was observed to be thick, indicating appropriate gel consistency. Adequate viscosity helps in maintaining the formulation at the site of application and ensures prolonged contact time for better therapeutic action.
  • The washability of the formulation was found to be easy, which is a desirable property for topical gels as it enhances user convenience and compliance.

CONCLUSION

The formulation of the herbal aromagel aimed to provide a natural and effective alternative to mitigate the adverse effects associated with prolonged corticosteroid use in asthma patients. It incorporated carefully selected herbal extracts known for their anti-inflammatory, bronchodilatory, antioxidant, and immunomodulatory properties, which were intended to complement conventional treatment by addressing inflammation, improving airway function, and supporting immune resilience. The choice of these herbs was based on their traditional medicinal use as well as scientific evidence supporting their therapeutic benefits in respiratory health.

The evaluation process focused extensively on ensuring the gel’s stability, safety, and efficacy through a series of physicochemical and sensory tests. Parameters such as pH, viscosity, texture, spreadability, and odor were meticulously assessed to confirm the product’s suitability for topical application and patient acceptability. Stability studies under various storage conditions were conducted to verify that the formulation maintained its physical integrity and biological activity over time. Additionally, microbial testing was performed to ensure the safety and preservative effectiveness within the gel matrix.

The herbal aromagel was intended to serve as a complementary therapeutic option that could support respiratory health, enhance patient compliance, and improve the overall quality of life for individuals managing asthma. By offering a natural, topical alternative, the formulation aimed to reduce common corticosteroid-related side effects such as throat irritation, immune suppression, and increased infection risk. This, in turn, was expected to encourage better adherence to asthma treatment regimens.

Future perspectives included validating the formulation’s therapeutic efficacy and safety through rigorous in vitro and in vivo studies, including clinical trials. These studies would provide critical data to support the aromagel’s role as a valuable adjunct in asthma management. Ultimately, the project envisioned that this herbal aromagel could be integrated into standard treatment protocols, providing patients with a holistic approach that combines the benefits of herbal medicine with modern pharmacotherapy to achieve improved respiratory health outcomes.

REFERENCES

  1. National Heart Lung and Blood Institute. Guidelines for the diagnosis and management of asthma (EPR-3) 2007. http://www. nhlbi. nih. gov/guidelines/asthma/. 2015.
  2. Ober C, Yao TC. The genetics of asthma and allergic disease: a 21st century perspective. Immunological reviews. 2011 Jul;242(1):10-30.
  3. Holloway JW, Yang IA, Holgate ST. Genetics of allergic disease. Journal of Allergy and Clinical Immunology. 2010 Feb 1;125(2):S81-94.
  4. Harb H, Renz H. Update on epigenetics in allergic disease. Journal of Allergy and Clinical Immunology. 2015 Jan 1;135(1):15-24.
  5. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, Printz MC, Lee WM, Shult PA, Reisdorf E, Carlson-Dakes KT. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. American journal of respiratory and critical care medicine. 2008 Oct 1;178(7):667-72.
  6. Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respiratory medicine. 2006 Aug 1;100(8):1307-17.
  7. DeChristopher LR, Uribarri J, Tucker KL. Intakes of apple juice, fruit drinks and soda are associated with prevalent asthma in US children aged 2–9 years. Public health nutrition. 2016 Jan;19(1):123-30.
  8. Wong KO, Hunter Rowe B, Douwes J, Senthilselvan A. Asthma and wheezing are associated with depression and anxiety in adults: an analysis from 54 countries. Pulmonary medicine. 2013;2013(1):929028.
  9. Fahy JV. Type 2 inflammation in asthma present in most, absent in many. Nature Reviews Immunology. 2015 Jan;15(1):57-65.
  10. Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R, Le Souef P, Mäkelä M, Roberts G, Wong G, Zar H. International consensus on (ICON) pediatric asthma. Allergy. 2012 Aug;67(8):976-97.
  11. Dougherty RH, Fahy JV. Acute exacerbations of asthma: epidemiology, biology and the exacerbation?prone phenotype. Clinical & Experimental Allergy. 2009 Feb;39(2):193-202.
  12. Fajt ML, Wenzel SE. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. Journal of Allergy and Clinical Immunology. 2015 Feb 1;135(2):299-310.
  13. Corren J. Asthma phenotypes and endotypes: an evolving paradigm for classification. Discovery medicine. 2013 Apr 26;15(83):243-9.
  14. Orie NG, Sluiter HJ, editors. Bronchitis II. Thomas; 1964.
  15. Hargreave FE, Parameswaran K. Asthma, COPD and bronchitis are just components of airway disease. European Respiratory Journal. 2006 Jul 31;28(2):264-7.
  16. Adelroth E, Morris MM, Hargreave FE, O'byrne PM. Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls. New England Journal of Medicine. 1986 Aug 21;315(8):480-4.

Reference

  1. National Heart Lung and Blood Institute. Guidelines for the diagnosis and management of asthma (EPR-3) 2007. http://www. nhlbi. nih. gov/guidelines/asthma/. 2015.
  2. Ober C, Yao TC. The genetics of asthma and allergic disease: a 21st century perspective. Immunological reviews. 2011 Jul;242(1):10-30.
  3. Holloway JW, Yang IA, Holgate ST. Genetics of allergic disease. Journal of Allergy and Clinical Immunology. 2010 Feb 1;125(2):S81-94.
  4. Harb H, Renz H. Update on epigenetics in allergic disease. Journal of Allergy and Clinical Immunology. 2015 Jan 1;135(1):15-24.
  5. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, Printz MC, Lee WM, Shult PA, Reisdorf E, Carlson-Dakes KT. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. American journal of respiratory and critical care medicine. 2008 Oct 1;178(7):667-72.
  6. Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respiratory medicine. 2006 Aug 1;100(8):1307-17.
  7. DeChristopher LR, Uribarri J, Tucker KL. Intakes of apple juice, fruit drinks and soda are associated with prevalent asthma in US children aged 2–9 years. Public health nutrition. 2016 Jan;19(1):123-30.
  8. Wong KO, Hunter Rowe B, Douwes J, Senthilselvan A. Asthma and wheezing are associated with depression and anxiety in adults: an analysis from 54 countries. Pulmonary medicine. 2013;2013(1):929028.
  9. Fahy JV. Type 2 inflammation in asthma present in most, absent in many. Nature Reviews Immunology. 2015 Jan;15(1):57-65.
  10. Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R, Le Souef P, Mäkelä M, Roberts G, Wong G, Zar H. International consensus on (ICON) pediatric asthma. Allergy. 2012 Aug;67(8):976-97.
  11. Dougherty RH, Fahy JV. Acute exacerbations of asthma: epidemiology, biology and the exacerbation?prone phenotype. Clinical & Experimental Allergy. 2009 Feb;39(2):193-202.
  12. Fajt ML, Wenzel SE. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. Journal of Allergy and Clinical Immunology. 2015 Feb 1;135(2):299-310.
  13. Corren J. Asthma phenotypes and endotypes: an evolving paradigm for classification. Discovery medicine. 2013 Apr 26;15(83):243-9.
  14. Orie NG, Sluiter HJ, editors. Bronchitis II. Thomas; 1964.
  15. Hargreave FE, Parameswaran K. Asthma, COPD and bronchitis are just components of airway disease. European Respiratory Journal. 2006 Jul 31;28(2):264-7.
  16. Adelroth E, Morris MM, Hargreave FE, O'byrne PM. Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls. New England Journal of Medicine. 1986 Aug 21;315(8):480-4.

Photo
Gayatri Bhale
Corresponding author

Student, Shraddha Institute of Pharmacy, Kondala Zambre, Washim - 444505

Photo
Amruta Bawane
Co-author

Asst.proffessor, Shraddha Institute of Pharmacy, Kondala Zambre, Washim - 444505

Photo
Dr. S. Deshmukh
Co-author

Shraddha Institute of Pharmacy, Kondala Zambre, Washim - 444505

Gayatri Bhale, Amruta Bawane, Dr. S. Deshmukh, Formulation And Evaluation of Herbal Aromagel Against Steroid-Induced Adverse Effects in Asthma, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 4, 3905-3912, https://doi.org/10.5281/zenodo.19706958

More related articles
The Growth of Aromatherapy Candles Aesthetic and P...
Mohsin Abbas, Swati Khare, Dr. Jitendra Banweer, ...
Challenges and Quality Attributes in Fluidized Bed Processing Method in The Manu...
Gayatri Pawar, Dr. Vishal Yadav, Rutuja Sonawalkar, Dr. V. Y. Lokhande, ...
An Overview of Transdermal Drug Delivery System (TDDS) ...
Samata Korgaonkar , Gauri Bhivshet, Vijay Jagtap , ...
Related Articles
A Pharmacological Evaluation Of Antihistaminic And Anti Inflammatory Activity On...
Laxmi Sirvi, Rajendra S. Bapna, Ragini Bundela, Karunakar Shukla, ...
Phytochemical and in-vitro Pharmacological Evaluation of Rhizomes of Curcuma cae...
Amruta Kshirsagar, Ashpak Tamboli , Sagar Kale , Manojkumar Patil , Vaishnavi Chavan, Prerana Panchw...
Formulation Development and Evaluation of Herbal Tooth Paste ...
Shanthi M. V., Anaswara B., Manjusha C. P., Aiswarya. M., Aadiya Krishna, Ganga Jayachandrann, ...
A Comprehensive Review on the Ethnobotanical, Pharmacognostic, Phytochemical, an...
Probal Dhara, Sanchita Podder, Pallabi Mishra, Deepanjan Mondal, Avinaba Samanta, Sumanta Bhattachar...